TransCoastal Corp. engages in the provision of exploration and production of oil and natural gas properties. The company is headquartered in Dallas, Texas and currently employs 21 full-time employees. The firm is engaged in the areas of oil and gas exploration, development and production. The firm's focus has been to build an inventory of multi-prospect drilling programs. The firm is engaged in geology engineering and well work overs. The firm's operations use hydraulic fracturing to drill new oil and gas wells. Hydraulic fracturing is a process, which is used to release hydrocarbons, particularly natural gas from certain geological formations. The Company, through its subsidiary, evaluates opportunities to acquire oil and natural gas properties, and engages in bidding and negotiating for these acquisitions.
TransCoastal Corp 最大收入来源是 Oral Small-molecule and Injectable Protein Therapeutics,在最近的收益报告中收入为 450,712,000。就地区而言, United States 是 TransCoastal Corp 的主要市场,收入为 385,961,000。